Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials
- 1 July 2008
- journal article
- Published by Springer Science and Business Media LLC in Drug Information Journal
- Vol. 42 (4), 303-319
- https://doi.org/10.1177/009286150804200402
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Handling drop‐out in longitudinal clinical trials: a comparison of the LOCF and MMRM approachesPharmaceutical Statistics, 2007
- Missing Data in Clinical StudiesPublished by Wiley ,2007
- Attrition in Randomized Controlled Clinical Trials: Methodological Issues in PsychopharmacologyBiological Psychiatry, 2006
- Analyzing incomplete longitudinal clinical trial dataBiostatistics, 2004
- Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCFObesity Reviews, 2003
- Assessing and interpreting treatment effects in longitudinal clinical trials with missing dataBiological Psychiatry, 2003
- Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory ConsiderationsJournal of Biopharmaceutical Statistics, 2003
- COMPARISON OF ALTERNATIVE STRATEGIES FOR ANALYSIS OF LONGITUDINAL TRIALS WITH DROPOUTSJournal of Biopharmaceutical Statistics, 2002
- Type I Error Rates from Mixed Effects Model Repeated Measures Versus Fixed Effects Anova with Missing Values Imputed Via Last Observation Carried ForwardDrug Information Journal, 2001
- ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELSJournal of Biopharmaceutical Statistics, 2001